NxThera Completes $12.6 Million in Series B Financing for Treating BPH
NxThera Inc., a St. Paul, Minn.-based privately held medical devices company, has added $12.6 million in Series B financing.
benign prostatic hyperplasia
Urovalve Bladder Management System Shows Early Promise in Clinical Trial
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
Urologix and Uroplasty: Treatments for Common Urinary Disorders
Voiding the bladder is one of the most basic human functions, so mundane that we pay it little mind most of the time.